Patients Tackling inappropriate prescription practices for weight los... A critical issue within the pharmaceutical sector has been highlighted by the MHRA’s investigation into the improper prescription of Wegovy.
Market Access Weighing the pros and cons, and dollars and cents, of the ne... Obesity rates in the United States have tripled since the 1980s. According to the CDC, a mind-boggling 41.9% of adults were obese as of 2020.
Market Access Are we entering a new era of blockbuster weight-loss drugs? Has the industry found a new revenue driver in weight-loss treatments?
News BioMarin starts rebuilding after its downsizing spree BioMarin has made its first M&A play under James Sabry, buying Inozyme to flesh out its enzyme replacement therapies (ERTs) for rare diseases.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.